Live Breaking News & Updates on Wegovy And Weight Loss|Page 1

Stay updated with breaking news from Wegovy and weight loss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Study Estimates More than 90 Million US Adults Could Benefit from Semaglutide 2.4 mg

Using data and eligibility criteria from the STEP 1 trial, a California-based team estimates 93 million US adults met criteria for semaglutide 2.4 mg and use could prevent 1.5 million incident cardiovascular events over a 10-year period. ....

United States , Hridhay Karthikeyan , Nathand Wong , Heart Disease Prevention Program , University Of California , Nutrition Examination Survey , Novo Nordisk , Us National Health , Wenjun Fan , Estimated Impact , Semaglutide Treatment , Obesity Prevalence , Cardiovascular Disease Events , Cardiovasc Drugs , Semaglutide 2 4 Mg , Semaglutide 2 4 Mg Wegovy , Wegovy And Weight Loss , Weight Loss , Obesity Management ,